To our knowledge, this is the first report that ERO1α acts as a promoter in HCC, establishing a novel connection between ER stress-signaling pathways and cancer progression and suggesting that ERO1α may be a prognostic marker for HCC. This evidence concerns the gene ERO1A and cancer.